Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5mg.

Trial Profile

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5mg.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2017

At a glance

  • Drugs Amlodipine/atenolol; Amlodipine/valsartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms EXPLOR
  • Sponsors Novartis
  • Most Recent Events

    • 01 May 2010 Results presented at 25th Annual Scientific Meeting of the American Society of Hypertension.
    • 19 Apr 2010 Results published in Hypertension.
    • 16 Jun 2009 Primary endpoint results preseneted at the 19th European Meeting on Hypertension
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top